InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
KPTI
Result 348 decisions over 120 months
Reset filters
Direction ?
Both348 Bought4 Sold344
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: KPTI
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
KPTI Karyopharm Therapeutics Inc.
18 May 2018
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$193.87K
1.9%
KPTI Karyopharm Therapeutics Inc.
18 May 2018
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$193.87K
1.9%
KPTI Karyopharm Therapeutics Inc.
10 May 2018
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated
2,000
$36.02K
41.0%
KPTI Karyopharm Therapeutics Inc.
10 May 2018
Mirza Mansoor Raza
Director
Sold, plan not stated
2,000
$36.00K
100%
KPTI Karyopharm Therapeutics Inc.
7 May 2018
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$167.75K
1.4%
KPTI Karyopharm Therapeutics Inc.
7 May 2018
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$167.75K
1.4%
KPTI Karyopharm Therapeutics Inc.
18 Apr 2018
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$147.88K
1.9%
KPTI Karyopharm Therapeutics Inc.
18 Apr 2018
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$147.88K
1.9%
KPTI Karyopharm Therapeutics Inc.
9 Apr 2018
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$124.83K
1.4%
KPTI Karyopharm Therapeutics Inc.
9 Apr 2018
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$124.83K
1.4%
KPTI Karyopharm Therapeutics Inc.
19 Mar 2018
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$152.90K
1.9%
KPTI Karyopharm Therapeutics Inc.
19 Mar 2018
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$152.90K
1.9%
KPTI Karyopharm Therapeutics Inc.
12 Mar 2018
Mirza Mansoor Raza
Director
Sold, plan not stated
2,500
$42.53K
100%
KPTI Karyopharm Therapeutics Inc.
7 Mar 2018
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$161.46K
1.4%
KPTI Karyopharm Therapeutics Inc.
7 Mar 2018
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$161.46K
1.4%
KPTI Karyopharm Therapeutics Inc.
5 Mar 2018
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated
2,500
$40.08K
33.9%
KPTI Karyopharm Therapeutics Inc.
5 Mar 2018
Mirza Mansoor Raza
Director
Sold, plan not stated
2,500
$40.00K
100%
KPTI Karyopharm Therapeutics Inc.
20 Feb 2018
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$147.87K
1.9%
KPTI Karyopharm Therapeutics Inc.
20 Feb 2018
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$147.87K
1.9%
KPTI Karyopharm Therapeutics Inc.
16 Feb 2018
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated
1,486
$22.30K
16.8%
KPTI Karyopharm Therapeutics Inc.
15 Feb 2018
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated
1,014
$15.23K
10.3%
KPTI Karyopharm Therapeutics Inc.
8 Feb 2018
Mirza Mansoor Raza
Director
Sold, plan not stated
1,500
$21.00K
100%
KPTI Karyopharm Therapeutics Inc.
7 Feb 2018
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$125.05K
1.4%
KPTI Karyopharm Therapeutics Inc.
7 Feb 2018
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$125.05K
1.4%
KPTI Karyopharm Therapeutics Inc.
7 Feb 2018
Mirza Mansoor Raza
Director
Sold, plan not stated
1,500
$19.50K
100%
KPTI Karyopharm Therapeutics Inc.
7 Feb 2018
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated
1,500
$19.50K
13.2%
KPTI Karyopharm Therapeutics Inc.
18 Jan 2018
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$100.88K
1.9%
KPTI Karyopharm Therapeutics Inc.
18 Jan 2018
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$100.88K
1.9%
KPTI Karyopharm Therapeutics Inc.
8 Jan 2018
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$100.77K
1.4%
KPTI Karyopharm Therapeutics Inc.
8 Jan 2018
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$100.77K
1.4%
KPTI Karyopharm Therapeutics Inc.
18 Dec 2017
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$91.55K
1.9%
KPTI Karyopharm Therapeutics Inc.
18 Dec 2017
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$91.55K
1.9%
KPTI Karyopharm Therapeutics Inc.
12 Dec 2017
Primiano Christopher Brett
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated 2×
17,000
$168.62K
59.9%
KPTI Karyopharm Therapeutics Inc.
11 Dec 2017
Primiano Christopher Brett
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
10,042
$109.26K
46.9%
KPTI Karyopharm Therapeutics Inc.
7 Dec 2017
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$103.90K
1.4%
KPTI Karyopharm Therapeutics Inc.
7 Dec 2017
Shacham Sharon
President & CSO
Sold, plan not stated
10,000
$103.90K
1.4%
KPTI Karyopharm Therapeutics Inc.
7 Nov 2017
Frenkel Ran
Chief Dev Operations Officer
Sold, plan not stated
4,958
$55.76K
16.7%
KPTI Karyopharm Therapeutics Inc.
7 Nov 2017
Primiano Christopher Brett
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
4,958
$55.76K
18.8%
KPTI Karyopharm Therapeutics Inc.
2 Oct 2017
Mirza Mansoor Raza
Director
Sold, plan not stated
2,000
$24.00K
100%
KPTI Karyopharm Therapeutics Inc.
2 Oct 2017
Primiano Christopher Brett
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
1,500
$18.00K
11.6%
KPTI Karyopharm Therapeutics Inc.
15 Sep 2017
Mirza Mansoor Raza
Director
Sold, plan not stated
2,882
$31.70K
100%
KPTI Karyopharm Therapeutics Inc.
15 Sep 2017
Primiano Christopher Brett
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
2,000
$22.00K
13.4%
KPTI Karyopharm Therapeutics Inc.
11 Sep 2017
Mirza Mansoor Raza
Director
Sold, plan not stated
118
$1.30K
100%
KPTI Karyopharm Therapeutics Inc.
29 Aug 2017
Primiano Christopher Brett
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
2,195
$21.95K
12.3%
KPTI Karyopharm Therapeutics Inc.
26 Jun 2017
Primiano Christopher Brett
SVP, OPS, BUS DEV, GC & SEC
Sold, plan not stated
805
$8.07K
5.1%
KPTI Karyopharm Therapeutics Inc.
14 Nov 2016
Frenkel Ran
Chief Dev Operations Officer
Sold, plan not stated
3,309
$33.29K
18.4%
KPTI Karyopharm Therapeutics Inc.
9 Nov 2016
Renz Justin A
EVP, CFO & Treasurer
Sold, plan not stated
4,342
$35.54K
18.5%
KPTI Karyopharm Therapeutics Inc.
9 Nov 2016
Primiano Christopher Brett
SVP,CORP DEV,GEN COUNSEL&SEC.
Sold, plan not stated
4,342
$35.54K
21.5%
Showing 301–348 of 348. ← Newer Page 7 of 7